Hematoma Risk After Needle Electromyography in Patients Using Newer Oral Anticoagulants
Conclusions:
Patients on NOACs had minimal risk of clinically relevant hemorrhagic complications, and the risk is not significantly different from those on warfarin.
Source: Journal of Clinical Neurophysiology - Category: Neurology Tags: Original Research Source Type: research
More News: Bleeding | Brain | Coumadin | Neurology | Study | Thrombosis | Ultrasound | Vitamin K | Vitamins | Warfarin